[Clinical treatment of lithium induced tremors with a beta receptor antagonist (propranolol)].
D000275:Adjustment Disorders / Q000188:drug therapy; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy; D055598:Chemical Phenomena; D002621:Chemistry; D002986:Clinical Trials as Topic; D006236:Handwriting; D006801:Humans; D008094:Lithium / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology*; D009048:Motor Skills; D010300:Parkinson Disease / Q000188:drug therapy; D011433:Propranolol / Q000627:therapeutic use*; D014202:Tremor / Q000139:chemically induced / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D008094:Lithium; D011433:Propranolol
Klinische Behandlungsversuche des lithiumbedingten Tremors durch einen beta-Rezeptorenantagonisten (Propanolol.